In a new study published in Kidney International, researchers report that drugs known as SGLT2 inhibitors prevented age-related deterioration of kidney structure and function in the African turquoise killifish, a vertebrate that completes its entire lifespan in just a few months. The findings reveal specific biological mechanisms that may help explain why these drugs consistently protect kidney and cardiovascular health in people, beyond their original role in lowering blood sugar.
This article was originally published on MedicalXpress.com
